Tizanidine: Difference between revisions

>Goornie
m Adding more effects
>Goornie
Added table
Line 14: Line 14:


==Pharmacology==
==Pharmacology==
{{pharmacology}}
Tizanidine is an imidazoline derivative and centrally acting α2 receptor agonist closely related to Clonidine. Tizanidine inhibits the release of excitatory amino acids from spinal interneurons. As a result, Tizanidine enhances the presynaptic inhibition of motor neurons.  
Tizanidine is an imidazoline derivative and centrally acting α2 receptor agonist closely related to Clonidine. Tizanidine inhibits the release of excitatory amino acids from spinal interneurons. As a result, Tizanidine enhances the presynaptic inhibition of motor neurons.  


Line 22: Line 21:


Tizanidine has an oral bioavailability of 20-34% and an elimination half-life of 2.5 hours. It attains steady-state concentration within 24-48 hours after administration.
Tizanidine has an oral bioavailability of 20-34% and an elimination half-life of 2.5 hours. It attains steady-state concentration within 24-48 hours after administration.
The table below compares the selectivity of Tizanidine and other drugs to the imidzaoline-receptor and the α2 receptors in rats. Tizanidine has a significantly greater selectivity to the imidazoline receptor than clonidine. The imidazoline receptor selectivity of tizanidine may be responsible for its unique pharmacological profile<ref>S;, M. I. K. (n.d.). Tizanidine may discriminate between imidazoline-receptors and alpha 2-adrenoceptors. Japanese journal of pharmacology. Retrieved from https://pubmed.ncbi.nlm.nih.gov/1331591/ </ref>.
{| class="wikitable"
|-
! Drug
! Imidazoline receptors Ki (nM)
! α2 Receptors Ki (nM)
|-
| Tizanidine
| 4.17 ± 1.81
| 91.5 ± 9.1
|-
| Clonidine
| 9.20 ± 1.23
| 9.20 ± 1.23
|-
| Oxymethazoline
| 2.28 ± 0.36
| 25.9 ± 5.5
|-
| Naphazoline
| 309 ± 26
| 25.9 ± 5.5
|-
| Adrenaline
| > 10000
| 3.18 ± 0.41
|-
|}
==Subjective effects==
==Subjective effects==
{{Preamble/SubjectiveEffects}}
{{Preamble/SubjectiveEffects}}